Registry for Severe ROP and Treatment on Visual Outcomes

NCT01559571 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 324

Last updated 2020-06-30

No results posted yet for this study

Summary

The purpose of this study is to determine what factors influence the visual outcomes of infants with severe retinopathy of prematurity (ROP) and to monitor the outcomes.

Conditions

  • Retinopathy of Prematurity

Sponsors & Collaborators

  • Pediatrix

    lead OTHER

Principal Investigators

  • Reese H Clark, MD · Pediatrix

Eligibility

Max Age
7 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2020-05-15
Completion
2020-05-15

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01559571 on ClinicalTrials.gov